澳大利亚住院儿童革兰阴性血流感染特征及其临床结局
在澳大利亚5家儿童医院开展3年前瞻性研究,纳入931例次18岁以下儿童革兰阴性血流感染。71%患儿有基础疾病,60%留置中心静脉导管,71%分离株为肠杆菌目,其中22%对第三代头孢菌素耐药,该耐药与死亡率升高独立相关(调整比值比3.2,95%CI 1.6-6.4)。
要点
- 儿童革兰阴性血流感染多发生于5岁以下及有基础疾病者,常为医疗相关感染。
- 71%分离株为肠杆菌目,其中22%对第三代头孢菌素耐药。
- 第三代头孢菌素耐药肠杆菌目感染与死亡率升高独立相关(调整比值比3.2,95%CI 1.6-6.4)。
核心结论
- 儿童革兰阴性血流感染常为医疗相关,多见于5岁以下儿童,第三代头孢菌素耐药肠杆菌目感染与更差结局相关。
研究设计与样本
- 2019至2021年在澳大利亚5家儿童医院开展3年前瞻性研究,纳入931例次18岁以下儿童革兰阴性血流感染,行抗生素敏感性试验和全基因组测序。
主要发现
- 931例次感染涉及818名儿童,中位年龄3岁(四分位距0.6-8.5),62%(576/931)为社区发病,71%(661/931)有基础疾病,60%(558/931)留置中心静脉导管。
- 中心静脉导管(145/931)和尿路(149/931)是最常见感染源,各占16%;11%(100/931)需入住重症监护室,另11%(105/931)在重症监护室发生感染。
- 659/927(71%)分离株为肠杆菌目,其中22%(138/630)对第三代头孢菌素耐药;65/138(47%)耐药株确认产超广谱β-内酰胺酶基因,最常见为blaCTX-M-15(34/94,36%)和blaSHV-12(10/94,11%)。
- 共48例死亡,30天院内死亡率为3%(32/931);第三代头孢菌素耐药肠杆菌目感染与死亡率升高独立相关(调整比值比3.2,95%置信区间1.6-6.4)。
临床怎么用
- 作者认为这些发现将有助于制定最佳管理指南,并帮助确定未来抗菌药物临床试验的优先方向。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Gram-negative bloodstream infections (GNBSIs) more commonly occur in children with comorbidities and are increasingly associated with antimicrobial resistance. There are few large studies of GNBSIs in children that relate the clinical presentation, pathogen characteristics, and outcomes. METHODS: A 3-year prospective study of GNBSIs in children aged <18 years was conducted in 5 Australian children's hospitals between 2019 and 2021. The clinical characteristics, disease severity, and outcomes were recorded. Causative pathogens underwent antibiotic susceptibility testing and whole genome sequencing. RESULTS: There were 931 GNBSI episodes involving 818 children. Median age was 3 years (interquartile range, 0.6-8.5). A total of 576/931 episodes (62%) were community onset, though 661/931 (71%) occurred in children with comorbidities and a central venous catheter was present in 558/931 (60%). Central venous catheter (145/931) and urinary tract (149/931) were the most common sources (16% each). One hundred of 931 (11%) children required intensive care unit admission and a further 11% (105/931) developed GNBSIs in intensive care unit. A total of 659/927 (71%) isolates were Enterobacterales, of which 22% (138/630) were third-generation cephalosporin resistant (3GCR). Extended spectrum beta-lactamase genes were confirmed in 65/138 (47%) 3GCR Enterobacterales. Most common extended spectrum beta-lactamase genes were blaCTX-M-15 (34/94, 36%) and blaSHV-12 (10/94, 11%). There were 48 deaths overall and 30-day in-hospital mortality was 3% (32/931). Infections with 3GCR Enterobacterales were independently associated with higher mortality (adjusted odds ratio, 3.2; 95% confidence interval, 1.6-6.4). CONCLUSIONS: GNBSIs in children are frequently healthcare associated and affect children younger than age 5 years. Infections with 3GCR Enterobacterales were associated with worse outcomes. These findings will inform optimal management guidelines and help prioritize future antimicrobial clinical trials.
引用
- Wen SCH, Harris PNA, Forde B, et al. Characterization of Gram-negative Bloodstream Infections in Hospitalized Australian Children and Their Clinical Outcomes. Clin Infect Dis. 2024. PMID: 38917034. doi:10.1093/cid/ciae341
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。